CanSino Biologics Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 733
Employees
  • Stock Symbol
  • 06185
Stock Symbol
  • Share Price
  • $35.78
  • (As of Tuesday Closing)

CanSino Biologics General Information

Description

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Stock Exchange
HKG
Primary Office
  • 401-420, 4th Floor, Biomedical Park
  • 185 South Avenue, TEDA West District
  • Tianjin
  • China
+86 022 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CanSino Biologics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$35.78 $35.18 $18.22 - $57.99 $11B 247M 1.34M $0.38

CanSino Biologics Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 20,098,023 9,526,569 1,578,411
Revenue 313,721 2,684 0 171
EBITDA 82,936 (57,409) (22,597) (19,117)
Net Income 96,936 (57,412) (22,688) (20,903)
Total Assets 1,585,673 1,032,874 255,045 115,696
Total Debt 139,220 21,817 23,839 21,805
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CanSino Biologics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CanSino Biologics‘s full profile, request access.

Request a free trial

CanSino Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercializat
Biotechnology
Tianjin, China
733 As of 2020
00000
00000000000 00000

0000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
000000000000000
Beijing, China
0000 As of 0000
00000
000000 - 000 00000

0000000

nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CanSino Biologics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sinovac Corporation Beijing, China 0000 00000 000000 - 000 00000
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 00000 000000000
00000000 Formerly VC-backed Mainz, Germany 0000 00.000 00000000 00.000
00000000000 Formerly VC-backed Louisville, CO 0 00000 000000&0 00000
00 000000000 Corporation Beverly Hills, CA 0 000.00 00000000 000.00
You’re viewing 5 of 16 competitors. Get the full list »

CanSino Biologics Executive Team (9)

Name Title Board Seat Contact Info
Xuefeng Yu Ph.D Co-Founder, Executive Director, Chief Executive Officer & Chairman
Shou Chao Ph.D Chief Operating Officer & Executive Director
Tao Zhu Ph.D Co-Founder, Executive Director and Chief Scientific Officer
Helen Mao Ph.D Co-Founder and Senior Vice President
Dongxu Qiu Ph.D Co-Founder, Senior Vice President and Executive Director
You’re viewing 5 of 9 executive team members. Get the full list »

CanSino Biologics Board Members (2)

Name Representing Role Since
Nisa Leung Qiming Venture Partners Board Member 000 0000
Xuefeng Yu Ph.D CanSino Biologics Co-Founder, Executive Director, Chief Executive Officer & Chairman 000 0000
To view CanSino Biologics’s complete board members history, request access »

CanSino Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial